Drug intelligence / Profile preview

salicylic acid + lactic acid (Diomed Developments)

Development stage: Unknown
Lead developer: Dermal Laboratories
Modality: Small Molecules
Administration: Topical

Overview

Salactol is a topical keratolytic treatment formulated as a paint or gel, primarily used for the removal of warts, verrucas, corns, and calluses. It is a combination product containing salicylic acid (16.7% w/w) and lactic acid (16.7% w/w) in a collodion base. Salicylic acid works by softening the keratin in the skin, allowing for the mechanical removal of the affected tissue, while lactic acid acts to reduce the pH and enhance the keratolytic effect. The product is developed by Diomed Developments and marketed by Dermal Laboratories.

Brand names: SalactolSalatac Gel
Other names: Salactol Paint

Beyond the preview

Go deeper on salicylic acid + lactic acid (Diomed Developments).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on salicylic acid + lactic acid (Diomed Developments).

Explore the full profile